Stokes Capital Advisors LLC Increases Position in Danaher Co. (DHR)

Stokes Capital Advisors LLC increased its holdings in Danaher Co. (NYSE:DHR) by 4.5% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 22,160 shares of the conglomerate’s stock after purchasing an additional 945 shares during the period. Danaher makes up about 1.8% of Stokes Capital Advisors LLC’s investment portfolio, making the stock its 22nd largest position. Stokes Capital Advisors LLC’s holdings in Danaher were worth $2,926,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in DHR. HL Financial Services LLC boosted its stake in Danaher by 0.4% during the first quarter. HL Financial Services LLC now owns 19,148 shares of the conglomerate’s stock worth $2,528,000 after buying an additional 79 shares during the period. Cornerstone Advisors Inc. boosted its stake in shares of Danaher by 2.9% during the first quarter. Cornerstone Advisors Inc. now owns 2,783 shares of the conglomerate’s stock valued at $367,000 after purchasing an additional 79 shares during the period. First Personal Financial Services boosted its stake in shares of Danaher by 13.7% during the first quarter. First Personal Financial Services now owns 664 shares of the conglomerate’s stock valued at $88,000 after purchasing an additional 80 shares during the period. Carroll Financial Associates Inc. boosted its stake in shares of Danaher by 5.6% during the first quarter. Carroll Financial Associates Inc. now owns 1,534 shares of the conglomerate’s stock valued at $202,000 after purchasing an additional 82 shares during the period. Finally, Cookson Peirce & Co. Inc. boosted its stake in shares of Danaher by 1.8% during the first quarter. Cookson Peirce & Co. Inc. now owns 4,710 shares of the conglomerate’s stock valued at $622,000 after purchasing an additional 83 shares during the period. Institutional investors own 76.98% of the company’s stock.

A number of brokerages have recently issued reports on DHR. Zacks Investment Research raised shares of Danaher from a “hold” rating to a “buy” rating and set a $147.00 target price for the company in a research note on Tuesday, April 9th. Deutsche Bank boosted their target price on shares of Danaher to $130.00 and gave the company a “buy” rating in a research note on Tuesday, February 26th. Needham & Company LLC reissued a “buy” rating and set a $141.00 target price (up from $138.00) on shares of Danaher in a research note on Wednesday, April 17th. UBS Group boosted their target price on shares of Danaher from $125.00 to $144.00 and gave the company a “buy” rating in a research note on Tuesday, February 26th. Finally, Janney Montgomery Scott raised shares of Danaher from a “neutral” rating to a “buy” rating in a research note on Monday, February 25th. Two analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $131.75.

DHR stock opened at $131.10 on Friday. The company has a quick ratio of 1.74, a current ratio of 2.18 and a debt-to-equity ratio of 0.32. The stock has a market capitalization of $94.70 billion, a P/E ratio of 29.00, a PEG ratio of 2.56 and a beta of 1.02. Danaher Co. has a 1-year low of $94.59 and a 1-year high of $134.67.

Danaher (NYSE:DHR) last released its quarterly earnings data on Thursday, April 18th. The conglomerate reported $1.07 earnings per share for the quarter, beating the consensus estimate of $1.01 by $0.06. The firm had revenue of $4.88 billion during the quarter, compared to the consensus estimate of $4.80 billion. Danaher had a return on equity of 11.61% and a net margin of 12.04%. The firm’s quarterly revenue was up 3.9% on a year-over-year basis. During the same period in the previous year, the company posted $0.99 earnings per share. On average, sell-side analysts anticipate that Danaher Co. will post 4.77 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 26th. Investors of record on Friday, June 28th will be issued a $0.17 dividend. The ex-dividend date of this dividend is Thursday, June 27th. This represents a $0.68 annualized dividend and a dividend yield of 0.52%. Danaher’s payout ratio is currently 15.04%.

In other news, Chairman Mitchell P. Rales acquired 1,900 shares of the firm’s stock in a transaction that occurred on Friday, May 10th. The stock was purchased at an average cost of $130.78 per share, for a total transaction of $248,482.00. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Thomas Patrick Joyce, Jr. sold 183,878 shares of Danaher stock in a transaction dated Monday, April 29th. The shares were sold at an average price of $131.30, for a total value of $24,143,181.40. Following the completion of the sale, the chief executive officer now owns 302,377 shares of the company’s stock, valued at $39,702,100.10. The disclosure for this sale can be found here. Insiders sold 424,761 shares of company stock valued at $54,983,097 over the last 90 days. 11.40% of the stock is currently owned by corporate insiders.

TRADEMARK VIOLATION WARNING: “Stokes Capital Advisors LLC Increases Position in Danaher Co. (DHR)” was posted by WKRB News and is owned by of WKRB News. If you are reading this news story on another website, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright law. The legal version of this news story can be read at https://www.wkrb13.com/2019/05/18/stokes-capital-advisors-llc-increases-position-in-danaher-co-dhr.html.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

See Also: What Does Beta Mean In Stock Selection

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.